Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Filings indexed 2,308 across all filing types
Latest filing 2014-02-26 Report Publication Anno…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2014
Report Publication Announcement Classification · 99% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2014-02-26 Danish
Regulatory Filings 2014
Regulatory Filings Classification · 99% confidence The document text is extremely short (232 characters) and explicitly states that transactions are being reported 'in accordance with Section 28a of the Danish Securities Trading Act' concerning Novozymes B shares. Crucially, it directs the reader to 'Read the full announcement in PDF format.' This structure—a brief notification pointing to a full document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content relates to specific transactions (though not explicitly director dealings, it's a regulatory disclosure), and it's a short announcement pointing elsewhere, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, as it is announcing the publication of the detailed filing. If the content were detailed insider trading reports, DIRS would apply, but here it's a regulatory notice of a transaction report.
2014-02-26 English
Director's Dealing 2014
Director's Dealing Classification · 100% confidence The document text is extremely short (232 characters) and explicitly states that transactions are being reported 'in accordance with Section 28a of the Danish Securities Trading Act' concerning Novozymes B shares. Crucially, it directs the reader to 'Read the full announcement in PDF format.' This structure—a brief notification pointing to a full document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content relates to specific transactions (though not explicitly director dealings, it's a regulatory disclosure), and it's a short announcement pointing elsewhere, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, as it is announcing the publication of the detailed filing. If the content were detailed insider trading reports, DIRS would apply, but here it's a regulatory notice of a transaction report.
2014-02-25 English
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document is dated February 25, 2014, and explicitly states it is published pursuant to the Danish Securities Trading Act (Værdipapirhandelslovens paragraf 28a). It details a specific transaction: the sale of shares by a senior executive ('Koncerndirektør, Supply Operations') named Thomas Nagy. This structure—reporting personal share transactions by directors/executives—directly matches the definition for Director's Dealing (DIRS). The document is short and specific, confirming it is a regulatory disclosure of insider trading, not a general regulatory filing (RNS) or a report publication announcement (RPA).
2014-02-25 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly relates to the company acquiring its own shares. The filing category 'Transaction in Own Shares (POS)' is defined as the report of the company buying back or selling its own shares. Although the text mentions reading the full announcement in PDF format (suggesting RPA/RNS), the core content is the transaction itself, making POS the most specific classification for the *subject matter* described, especially given the very short length which often accompanies these specific transaction disclosures.
2014-02-21 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 99% confidence The document text details specific transactions where Novozymes has bought back its own B-shares as part of a previously announced share repurchase program (aktietilbagekøbsprogram). It provides daily transaction volumes, average purchase prices, and the total number of treasury shares held after the transactions. This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2014-02-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.